NewsBenzingaAkari Therapeutics presenta la solicitud PCT/US2026/45955 para ampliar su cartera de propiedad intelectual Akari Therapeutics presenta la solicitud PCT/US2026/45955 para ampliar su cartera de propiedad intelectual Benzinga 2026.10.01 12:26 (GMT+0) Open on Benzinga Other news 'YPF Investors Ask Supreme Court to Review Argentine Legal Win'- Bloomberg Evercore ISI Group Maintains In-Line on M&T Bank, Lowers Price Target to $230 JP Morgan Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $75 Evercore ISI Group Maintains Outperform on Morgan Stanley, Lowers Price Target to $215 Evercore ISI Group Maintains Outperform on KeyCorp, Lowers Price Target to $24 $100 Invested In HF Sinclair 5 Years Ago Would Be Worth This Much Today
JP Morgan Initiates Coverage On Enliven Therapeutics with Overweight Rating, Announces Price Target of $75
